Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Arnold

Showing results (191-200 of 229) with videos related to

Pageof 23
Sort By:
Plos One|December 2, 2016
Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN RestorationW David Arnold, Sandra Duque, Chitra C Iyer, et al.
Annals of Clinical and Translational Neurology|December 13, 2024
Neuromuscular transmission deficits in patients with CMT and ClC-1 inhibition in CMT animal modelsThomas Skjærlund Grønnebæk, Helga Haahr-Lillevang, Martin Skov, et al.
Life Science Alliance|January 9, 2023
Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19Christopher M Rice, Philip Lewis, Fernando M Ponce-Garcia, et al.
Plos Medicine|January 30, 2023
Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A Mendelian randomisation studyFergus W Hamilton, Matt Thomas, David Arnold, et al.
Frontiers in Microbiomes|March 19, 2026
Microbial dysbiosis in melasma through community profilingYugandhar Reddy B S, Chandraprabha Doraiswamy, Deepshikha Singh, et al.
Research Square|April 8, 2025
Targeting senescence in Amyotrophic Lateral Sclerosis: senolytic treatment improves neuromuscular function and preserves cortical excitability in a TDP-43<sup>Q331K</sup> mouse modelJose A Viteri, Nathan R Kerr, Charles D Brennan, et al.
Pediatric Pulmonology|December 15, 2018
Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapySamiah Al-Zaidy, A Simon Pickard, Kavitha Kotha, et al.
Wellcome Open Research|August 8, 2022
Evaluation of perturbed iron-homeostasis in a prospective cohort of patients with COVID-19Joe N Frost, Fergus Hamilton, David Arnold, et al.
Clinical Science (London, England : 1979)|November 22, 2021
The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular diseaseElisa Avolio, Michele Carrabba, Rachel Milligan, et al.
Journal of Neuromuscular Diseases|November 15, 2021
Neurofilament Levels in CSF and Serum in an Adult SMA Cohort Treated with NusinersenKelly A Rich, Ashley Fox, Mehmet Yalvac, et al.
Pageof 23

Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
Plos One|December 2, 2016
Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN RestorationW David Arnold, Sandra Duque, Chitra C Iyer, et al.
Annals of Clinical and Translational Neurology|December 13, 2024
Neuromuscular transmission deficits in patients with CMT and ClC-1 inhibition in CMT animal modelsThomas Skjærlund Grønnebæk, Helga Haahr-Lillevang, Martin Skov, et al.
Life Science Alliance|January 9, 2023
Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19Christopher M Rice, Philip Lewis, Fernando M Ponce-Garcia, et al.
Plos Medicine|January 30, 2023
Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A Mendelian randomisation studyFergus W Hamilton, Matt Thomas, David Arnold, et al.
Frontiers in Microbiomes|March 19, 2026
Microbial dysbiosis in melasma through community profilingYugandhar Reddy B S, Chandraprabha Doraiswamy, Deepshikha Singh, et al.
Research Square|April 8, 2025
Targeting senescence in Amyotrophic Lateral Sclerosis: senolytic treatment improves neuromuscular function and preserves cortical excitability in a TDP-43<sup>Q331K</sup> mouse modelJose A Viteri, Nathan R Kerr, Charles D Brennan, et al.
Pediatric Pulmonology|December 15, 2018
Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapySamiah Al-Zaidy, A Simon Pickard, Kavitha Kotha, et al.
Wellcome Open Research|August 8, 2022
Evaluation of perturbed iron-homeostasis in a prospective cohort of patients with COVID-19Joe N Frost, Fergus Hamilton, David Arnold, et al.
Clinical Science (London, England : 1979)|November 22, 2021
The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular diseaseElisa Avolio, Michele Carrabba, Rachel Milligan, et al.
Journal of Neuromuscular Diseases|November 15, 2021
Neurofilament Levels in CSF and Serum in an Adult SMA Cohort Treated with NusinersenKelly A Rich, Ashley Fox, Mehmet Yalvac, et al.
Pageof 23